[Regression during chemotherapy of lytic bone lesions in a patient with type B malignant non-Hodgkin's lymphoma].

Pertuiset, E; Leblond-Missenard, V; Raphaël, M; Gabarre, J; Binet, J L; Dombret, M C

[Regression during chemotherapy of lytic bone lesions in a patient with type B malignant non-Hodgkin's lymphoma]. / Régression sous chimiothérapie des lésions osseuses lytiques dans un cas de lymphome malin non hodgkinien de type B.

Pertuiset, E; Leblond-Missenard, V; Raphaël, M; Gabarre, J; Binet, J L; Dombret, M C.

Rev Rhum Mal Osteoartic ; 56(12): 883-5, 1989 Dec.

Article in Fr | MEDLINE | ID: mdl-2617099

Subject(s)

Bone Neoplasms/drug therapy; Lymphoma, Non-Hodgkin/drug therapy; Osteolysis/drug therapy; Acromion; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Clavicle; Humans; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteolysis / Bone Neoplasms / Lymphoma, Non-Hodgkin Limits: Humans / Male / Middle aged Language: Fr Journal: Rev Rhum Mal Osteoartic Year: 1989 Document type: Article Country of publication: France

Search on Google

Add to My VHL

XML

PubMed Links